Inclusion Criteria | Â |
---|---|
Self-reported history of any one of the following CVD or risk factors in the 45 and Up Study baseline dataset | Report of treatment in the last month for: • Heart attack/angina • Other heart disease • High blood pressure • High blood cholesterol |
 | Report of taking any of the following in past four weeks: • Lipitor • Pravachol • Aspirin for the heart • Avapro/Karvea • Coversyl/Coversyl Plus • Cardizem/Vasocardol • Norvasc • Tritace • Noten • Tenormin/atenolol • Warfarin/Coumadin • Lasix/frusemide • Micardis |
 | Previous doctor's diagnosis of heart disease or stroke or high blood pressure |
 | Previous diagnosis of diabetes and taking at least one prescription of glucose lowering therapy in the last four weeks |
 | Two or more of the following risk factors: • Regular smoker now • Obese (Body Mass Index ≥ 30) • Over 65 years • Family history of heart disease or stroke in two or more first degree relatives |
Self-reported psychological distress in the 45 and Up Study baseline dataset | A Kessler-10 (K-10) score of greater than or equal to 16. |
Depressive symptoms indicated at pre-trial screening | A score of eight or above on the 27 point Patient Health Questionnaire (PHQ-9) |
Exclusion Criteria | Â |
No depressive symptoms at pre-trial screening | A score less than or equal to seven on the 27 point scale of the PHQ-9 |
Suicide ideation at pre-trial screening | A score of either '2' or '3' on the 0-3 likert scale at question nine of the PHQ-9 |
Currently receiving psychotherapy at pre-trial screening | Indication that currently receiving any form of counselling e.g. with a counsellor, GP, psychiatrist or psychologist |